Categories: News

THE ADECCO GROUP Q3 2025 RESULTS

AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange

- Advertisement -

Strong share gains, good growth and improved profit margin

- Advertisement -

ZURICH, Nov. 6, 2025 /PRNewswire/ —

- Advertisement -

 

- Advertisement -

HIGHLIGHTS

- Advertisement -
  • Further strong market share gains, Group +375 bps and Adecco +300 bps
  • Group revenues +3.4% yoy, and +3.0% qoq, with all GBUs improving sequentially
  • Adecco GBU revenues +4.5% yoy; Europe returned to growth; Americas +20% yoy, APAC +9% yoy
  • Akkodis GBU revenues -3% yoy; German turnaround progressing well
  • LHH GBU revenues +4% yoy, led by CT +9% yoy, Ezra +59% yoy
  • Healthy 19.2% gross margin, -10 bps yoy organic, and +30 bps sequentially, reflecting business mix, firm pricing
  • Solid 3.4% EBITA margin excl. one-offs, +10 bps yoy, reflecting good operating leverage, with productivity +8% yoy
  • Operating income €160 million, +2% yoy; Net income €89 million, -2% yoy
  • Basic EPS €0.53; Adjusted EPS €0.67
  • Strong 110% LTM cash conversion; solid operating cash flow of €200 million, up €79 million yoy
  • ND/EBITDA -0.3x qoq, with net debt €220 million lower yoy

Denis Machuel, Adecco Group CEO, commented:

- Advertisement -

“Our positive trajectory has continued in mixed markets, with further market share gains and good growth. We have improved margins by 90 basis points compared to the last quarter, demonstrating strong operating leverage. We thank our teams for yet another quarter of rigorous execution. We remain on track to reach our full year margin commitment.

- Advertisement -

“We are particularly pleased with Adecco’s strong results, with solid growth across multiple regions. Akkodis improved sequentially with our German turnaround progressing well. LHH returned to growth, supported by continued strength from Career Transition.

- Advertisement -

“We look forward to sharing the evolution of our strategy and detailed value creation plans at our Capital Markets Day in London on 26 November.”

- Advertisement -

Full Press Release

- Advertisement -

Webcast Details | Investors & Analysts

- Advertisement -

For further information, please contact:

- Advertisement -


Investor Relations


investor.relations@adeccogroup.com


+41 (0)44 878 88 88


Press Office


media@adeccogroup.com


+41 (0) 79 876 09 21

Logo: https://mma.prnewswire.com/media/2608173/5604293/The_Adecco_Group_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/the-adecco-group-q3-2025-results-302606146.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

5 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

9 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

9 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

9 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

9 hours ago